| COMMON NAME |
ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000 |
|---|---|
| SYNONYMS |
CD22;SIGLEC2;BL-CAM;SIGLEC-2;Siglec2;SIGLEC2FLJ22814 |
| APPLICATIONS |
ELISA |
| RECOMMENDED DILUTIONS |
ELISA 1:5000-10000 |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| HOST SPECIES |
Humanized |
| IGG TYPE |
IgG1 |
| REACTIVITY |
Human |
| TARGET | |
| UNIPROT ID |
P20273 |
| DESCRIPTION |
Anti-CD22 (pinatuzumab biosimilar) mAb |
| DELIVERY |
In Stock |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):BME100029
Anti-CD22 (pinatuzumab biosimilar) mAb
Anti-CD22 (pinatuzumab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human CD22, hFc-His tagged protein (PME100005) can bind Anti-CD22 Neutralizing antibody in a linear range of 3.2-400 ng/ml. In order to specifically detect BME100029, mouse anti-human Fab-specific antibody was used as detection antibody.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD22 (A) were surface stained with Anti-CD22 mAb 1 μg/ml (pinatuzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.
